What is Arthrosurface?
Arthrosurface operates at the intersection of advanced engineering and clinical orthopedics, specializing in motion-preserving joint replacement solutions. The company addresses the critical needs of patients suffering from joint pain and arthritis by offering minimally invasive alternatives to traditional total joint replacements. By focusing on preserving natural anatomy, Arthrosurface enables active patients to maintain their lifestyles while significantly reducing recovery times. Their comprehensive product portfolio is supported by a robust ecosystem of surgical literature and a network of trained medical professionals, ensuring that both providers and patients have access to high-quality, evidence-based orthopedic care.
How much funding has Arthrosurface raised?
Arthrosurface has raised a total of $29.2M across 7 funding rounds:
Series A
$336K
Series B
$2M
Series D
$10.5M
Series E
$5M
Other Financing Round
$1M
Series F
$5M
Series A
$5.3M
Series A (2002): $336K, investors not publicly disclosed
Series B (2003): $2M led by Boston Millennia Partners
Series D (2005): $10.5M supported by Boston Millennia Partners
Series E (2006): $5M featuring Boston Millennia Partners
Other Financing Round (2007): $1M backed by Boston Millennia Partners
Series F (2007): $5M with participation from Boston Millennia Partners
Series A (2021): $5.3M led by Boston Millennia
Key Investors in Arthrosurface
Boston Millennia Partners
Boston Millennia Partners is a private equity firm specializing in high-growth healthcare and life sciences companies, leveraging decades of operational and financial expertise to drive portfolio success.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Arthrosurface?
With the backing of major strategic investment, Arthrosurface is well-positioned to accelerate its research and development initiatives, particularly in the refinement of its surgical instrumentation and patient outcome tracking. The company's forward-looking strategy likely involves scaling its market presence and deepening its penetration into global orthopedic markets. As the demand for less invasive, high-performance joint solutions continues to rise, Arthrosurface's focus on long-term joint health and functional restoration will remain the cornerstone of its operational roadmap. Future growth will likely be driven by continued clinical validation and the expansion of its educational resources for surgeons, further cementing its role as a leader in the orthopedic technology landscape.
See full Arthrosurface company page
